Key result
Review highlights evolving roles of biomarkers, echocardiography, and CMR in diagnosing pediatric heart failure.
Why the study?
Pediatric heart failure carries high mortality, and early diagnosis is crucial for treatment and management as diagnostic modalities continue to evolve.
This review summarizes current diagnostic modalities for pediatric heart failure, including biomarkers, imaging, and clinical models, to guide early diagnosis and management.
May inform multimodal diagnostics in pediatric HF; leaves open prospective validation studies.
Heart failure is a complex clinical syndrome and pediatric heart failure (PHF) has a high mortality rate. Early diagnosis is crucial for treatment and management of PHF. In clinical practice, various tests and examinations play a key role in the diagnosis of PHF, including continuously updated biomarkers, echocardiography, and cardiac magnetic resonance imaging. This article focuses on summarizing relevant research on biomarkers, examinations, combined testing, clinical models, and the grading and staging of PHF diagnosis, aiming to provide insights and directions for the diagnosis of PHF.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) conducted a review in Pediatric heart failure. Diagnostic methods (biomarkers, echocardiography, cardiac MRI) was evaluated. This review summarizes recent research progress on the diagnosis of pediatric heart failure, highlighting the roles of biomarkers, echocardiography, and cardiac magnetic resonance imaging.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: